Tenet Healthcare CORP Stock: price and insider trades · United States · SEC (Form 4) Track the Tenet Healthcare CORP stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on US US, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Tenet Healthcare CORP has recorded 236 reports. Market capitalisation: €21.1bn. The latest transaction was filed on 10 August 2026 (Cession). Among the most active insiders: Arbour Paola M. The full history is free.
Analyst consensus: bullish or bearish? Analysts rate Tenet Healthcare CORP Strong Buy (bullish), based on 21 analysts. Average price target: US$281.76.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 2,640 of 28,257 companies
FCF yld 12%
Earn yld 6.7%
EV/EBITDA 7.6x
ROE 37%
Gross mgn 82%
Net mgn 6.6%
Debt/EBITDA 2.9x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
Generate AI analysis AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 10 August 2026
All Executives236 Thresholds0 Prospectus0 Other0
Declarations 236 total
▼ Director · Executives · 6 Aug 2026
4,922 shares @ US$264.15 Common Stock SEC:0001193125-26-342970:0
▼ Director · Executives · 7 Aug 2026
2,500 shares @ US$260.83 Common Stock SEC:0001193125-26-342970:1
● Director · Executives · 7 Aug 2026
2,500 shares @ US$260.825 0.0031% mcap 15.0% of flow Common SEC144:0001959173-26-005756
▼ Director · Executives · 5 Aug 2026
600 shares @ US$262.68 0.0008% mcap 39.4% of flow Common Stock SEC:0001193125-26-340735:0
● Director · Executives · 6 Aug 2026
4,922 shares @ US$264.15 0.0064% mcap 35.0% of flow Common SEC144:0001959173-26-005702
● Director · Executives · 5 Aug 2026
600 shares @ US$262.6773 0.0008% mcap 65.0% of flow Common SEC144:0001959173-26-005670
▼ EVP, Chief Operating Officer · Executives · 29 Jul 2026
10,000 shares @ US$258.03 0.013% mcap 38.7% of flow Common Stock SEC:0001193125-26-329146:0
● Officer · Executives · 29 Jul 2026
10,000 shares @ US$258.0295 0.012% mcap 63.2% of flow Common SEC144:0001959173-26-005434
▼ Director · Executives · 27 Jul 2026
3,837 shares @ US$243.44 0.0044% mcap 23.9% of flow Common Stock SEC:0001193125-26-321682:0
▼ EVP, Chief Information Officer · Executives · 27 Jul 2026
10,878 shares @ US$243.90 0.013% mcap 15.2% of flow Common Stock SEC:0001193125-26-321681:0
▼ Director · Executives · 27 Jul 2026
5,000 shares @ US$244.96 0.0058% mcap 21.4% of flow Common Stock SEC:0001193125-26-321680:0
● Officer · Executives · 27 Jul 2026
10,878 shares @ US$243.9013 0.013% mcap 17.9% of flow Common SEC144:0001959173-26-005386
● Director · Executives · 27 Jul 2026
5,000 shares @ US$244.9616 0.0058% mcap 27.2% of flow Common SEC144:0001959173-26-005380
◇ Director · Executives · 22 May 2026
1,333 shares Common Stock SEC:0001193125-26-239937:0
◇ Director · Executives · 22 May 2026
1,333 shares Common Stock SEC:0001193125-26-239943:0
◇ Director · Executives · 22 May 2026
1,333 shares Common Stock SEC:0001193125-26-239933:0
● Director · Executives · 22 May 2026
493 shares @ US$173.78 0.0004% mcap 100.0% of flow Common Stock SEC:0001193125-26-239933:1
▼ EVP, Chief Information Officer · Executives · 11 Mar 2026
6,500 shares @ US$238.43 12.5% of flow Common Stock SEC:0001193125-26-106696:0
▼ EVP, Chief Admin. Officer & GC · Executives · 9 Mar 2026
4,714 shares @ US$238.42 0.0058% mcap 18.2% of flow Common Stock SEC:0001193125-26-100724:0
▼ EVP, Chief Admin. Officer & GC · Executives · 9 Mar 2026
3,286 shares @ US$239.46 0.0040% mcap 12.7% of flow Common Stock SEC:0001193125-26-100724:1
◇ CEO · Executives · 27 Feb 2026
22,417 shares Common Stock SEC:0001193125-26-089422:0
◇ EVP & Chief Financial Officer · Executives · 27 Feb 2026
4,670 shares Common Stock SEC:0001193125-26-089418:0
◇ EVP, Chief Information Officer · Executives · 27 Feb 2026
1,868 shares Common Stock SEC:0001193125-26-089416:0
◇ EVP, Chief Operating Officer · Executives · 27 Feb 2026
4,670 shares Common Stock SEC:0001193125-26-089415:0
◇ Principal Accounting Officer · Executives · 27 Feb 2026
934 shares Common Stock SEC:0001193125-26-089412:0
25 of 236 declarations
Load more (211 remaining) 关于 Tenet Healthcare CORP Tenet Healthcare Corp. (NYSE: THC) 是一家多元化医疗保健服务公司,总部位于美国德克萨斯州达拉斯。该公司在纽约证券交易所上市,并在菲律宾设有全球业务中心,以支持企业范围内的行政职能。随着时间的推移,Tenet 已从传统的医院运营商发展成为一个更广泛的医疗保健平台,涵盖急性护理、专科护理、门诊手术、医生服务和收入周期管理。([investor.tenethealth.com](https://investor.tenethealth.com/home/default.aspx?c=SVBEM&utm_source=openai))
Tenet 的商业模式围绕三个主要支柱组织。首先是 USPI (United Surgical Partners International),其全国门诊手术平台。其次是医院运营,包括急性护理和专科医院、雇佣医生网络以及门诊设施,如紧急护理中心、影像中心、院外急诊科和微型医院。第三是 Conifer Health Solutions,为医院、卫生系统、医生诊所、雇主和其他客户提供收入周期管理及相关支持服务。这种组合使 Tenet 能够涉足住院护理、门诊手术和行政医疗保健基础设施,使其比纯粹的医院运营商更加多元化。([sec.gov](https://www.sec.gov/Archives/edgar/data/70318/000007031825000009/thc-20241231.htm?utm_source=openai))
截至2024年12月31日,Tenet 在其医院运营部门报告了49家急性护理和专科医院以及135家门诊设施,同时提供与 Conifer 相关的服务。其 USPI 设施专注于手术密集型专科,如骨科、全关节置换、胃肠病学、疼痛管理、耳鼻喉科、眼科和泌尿科。这些业务线具有战略重要性,因为它们符合程序从医院环境向成本较低的门诊场所长期转移的趋势,这一趋势支持利用率增长和运营效率。([sec.gov](https://www.sec.gov/Archives/edgar/data/70318/000007031825000009/thc-20241231.htm?utm_source=openai))
对于投资者而言,关键在于 Tenet 主要是一家美国医疗保健运营商,拥有广泛的全国业务布局,而非区域集中型。该公司在一个高度监管、对报销敏感的市场中竞争,因此盈利能力取决于付款人组合、定价纪律、劳动力管理以及在医院和门诊平台上的执行力。同时,医院、ASC 和收入周期服务的结合为 Tenet 提供了多种实现增长和提高利润的方式,同时也在护理环境和客户类型方面提供了一定的多元化。([sec.gov](https://www.sec.gov/Archives/edgar/data/70318/000007031825000009/thc-20241231.htm?utm_source=openai))
近期发展表明其发展势头强劲。2025年,Tenet 报告了强劲的季度业绩,包括收入增长和更高的调整后 EBITDA,并上调了全年展望。2026年2月,该公司宣布完成了涉及 Conifer Health Solutions 和 CommonSpirit Health 的战略交易,并表示2025年全年调整后 EBITDA 可能会达到指导范围的上限。运营业绩和资产负债表灵活性的结合,巩固了 Tenet 作为一家规模化的美国医疗保健服务平台,盈利能力不断提升的形象。([investor.tenethealth.com](https://investor.tenethealth.com/press-releases/press-release-details/2025/Tenet-Reports-Strong-Second-Quarter-2025-Results-Raises-2025-Financial-Outlook/default.aspx?utm_source=openai))